Validation Study of the OHIO Chamber in Patients with Japanese Cedar Pollinosis
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Background: An artificial exposure chamber (OHIO Chamber), which allows dispersal of a fixed concentration of Japanese cedar (JC) pollen under stable conditions, was constructed. This study was conducted to identify the exposure conditions assuring validity of the clinical tests conducted using this chamber. Methods: Twenty-four adult patients with JC pollinosis were exposed to different concentrations of JC pollen: 0 (only during the summer period), 4,000, 8,000 and 12,000 grains/m 3, and the nasal and ocular symptoms were self-assessed during a 4-hour period of exposure. The amount of nasal discharge was measured and the sneezing frequency was recorded. This study was conducted twice during the summer and winter periods, i.e. non-pollen seasons. The reproducibility of the symptoms between the two seasons was assessed. Results: None of the subjects developed any symptom at the pollen concentration of 0 grains/m 3. No significant differences in the time to the onset of symptoms were found between the summer and winter study, regardless of the pollen concentration. There were no significant differences between the summer and winter study in the total symptom score and total nasal symptom score at any pollen concentration, suggesting the very favorable reproducibility of symptoms. Conclusions: Efficient and reproducible results are obtained in patients exposed to JC pollen in the OHIO Chamber. The results suggest the conditions of JC pollen exposure have scientific validity and the OHIO Chamber has the potential to contribute significantly to basic and clinical studies of JC pollinosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many ACCs have been intensively validated regarding specificity and dose-dependency of symptom induction as well as technical aspects such as temporal stability and spatial homogeneity of the allergen exposure.1029-1037”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [1032]
Citations
Cites
Epidemiology of Japanese cedar pollinosis throughout Japan
Okuda, M. (2003) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)63532-6 · Cited by 177
Horak, F., Stübner, U. P., Zieglmayer, R., & Harris, A. G. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.124657 · Cited by 111
Krug, N., Loedding, H., Hohlfeld, J. M., Larbig, M., Buckendahl, A., Badorrek, P., Geldmacher, H., Behnke, W., Dunkhorst, W., Windt, H., et al. (2003) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2003.01810.x · Cited by 73
Patel, D., Garadi, R., Brubaker, M., Conroy, J. P., Kaji, Y., Crenshaw, K., Whitling, A., & Wall, G. M. (2007) · Allergy and Asthma Proceedings · doi:10.2500/aap2007.28.3033 · Cited by 67
Okubo, K., Gotoh, M., Shimada, K., Ritsu, M., Okuda, M., & Crawford, B. (2005) · International Archives of Allergy and Immunology · doi:10.1159/000083322 · Cited by 61
Self-citationDay, J. H., Horak, F., Briscoe, M. P., Canonica, G. W., Fineman, S. M., Krug, N., Leynadier, F., Lieberman, P., Quirce, S., Takenaka, H., et al. (2006) · Clinical & Experimental Allergy Reviews · doi:10.1111/j.1365-2222.2005.00099.x · Cited by 57
Stübner, P., Horak, F., Zieglmayer, R., Arnáiz, E., Leuratti, C., Pérez, I., & Izquierdo, I. (2006) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)61038-1 · Cited by 56
Day, J. H., Briscoe, M. P., Rafeiro, E., Chapman, D. S., & Krämer, B. (2001) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)62260-0 · Cited by 56
Berkowitz, R. B., Woodworth, G. G., Lutz, C., Weiler, K., Weiler, J., Moss, M., & Meeves, S. (2002) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)61909-6 · Cited by 38
Horak, F., Toth, J., Marks, B., Stübner, U. P., Berger, U. E., Jäger, S., Burtin, B., & Duby, C. (1998) · Allergy · doi:10.1111/j.1398-9995.1998.tb03990.x · Cited by 32
Research works printed but not linked: 1
- 10.1067%2Fmai.2001.118891 · DOI · Paper page
Cited by
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
Rösner-Friese, K., Kaul, S., Vieths, S., & Pfaar, O. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.10.045 · Cited by 66
Jacobs, R. L., Harper, N., He, W., Andrews, C. P., Rather, C. G., Ramirez, D., & Ahuja, S. K. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.03.031 · Cited by 62
Technical standards in allergen exposure chambers worldwide – an EAACI Task Force Report
Pfaar, O., Bergmann, K., Bonini, S., Compalati, E., Domis, N., de Blay, F., de Kam, P., Devillier, P., Durham, S. R., Ellis, A. K., et al. (2021) · Allergy · doi:10.1111/all.14957 · Cited by 39
“We determined that 8000 grains/m3 of Japanese cedar pollen and 12000 grains/m3 of cypress pollen are sufficient to induce symptoms (39).”
BackgroundOkubo, K., Gotoh, M., Asako, M., Nomura, Y., Togawa, M., Saito, A., Honda, T., & Ohashi, Y. (2016) · Allergology International · doi:10.1016/j.alit.2016.05.014 · Cited by 40
Self-citationValidation of the biogenics research chamber for Juniperus ashei (mountain cedar) pollen
Jacobs, R. L., Ramirez, D. A., & Andrews, C. P. (2011) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2011.04.009 · Cited by 30
Jacobs, R. L., Harper, N., He, W., Andrews, C. P., Rather, C. G., Ramirez, D., & Ahuja, S. K. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.051 · Cited by 29
Hashiguchi, K., Tang, H., Fujita, T., Suematsu, K., Gotoh, M., & Okubo, K. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902758368 · Cited by 22
“To achieve a stable environment, since the amount of dispersed pollen grains and climate cannot be controlled in the natural environment, we conducted this study in a recently built (Tokyo, 2005) pollen exposure chamber (OHIO chamber) [7].”
MethodSelf-citationCharacteristics of the Chiba Environmental Challenge Chamber
Hamasaki, S., Okamoto, Y., Yonekura, S., Okuma, Y., Sakurai, T., Iinuma, T., Yamamoto, H., Sakurai, D., Horiguchi, S., & Yokota, M. (2014) · Allergology International · doi:10.2332/allergolint.13-oa-0578 · Cited by 19
Ramírez, D. A., Andrews, C. P., Rather, C. G., & Jacobs, R. L. (2014) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2014.11.006 · Cited by 16
Method for a homogeneous distribution of pollens in an environmental exposure chamber
Kenney, P. S., Bønløkke, J. H., Hilberg, O., Ravn, P., Schlünssen, V., & Sigsgaard, T. (2016) · Clinical & Experimental Allergy · doi:10.1111/cea.12747 · Cited by 10
Hashiguchi, K., Wakabayashi, K.-I., Togawa, M., Saito, A., & Okubo, K. (2016) · Allergology International · doi:10.1016/j.alit.2016.06.009 · Cited by 9
Self-citationTechnical and clinical validation of an environmental exposure unit for ragweed
Gomes, P. J., Lane, K. J., Angjeli, E., Stein, L., & Abelson, M. B. (2016) · Journal of Asthma and Allergy · doi:10.2147/jaa.s123547 · Cited by 8
“…Institute Environmental Challenge Chamber in Germany; 7 the GA 2 LEN chamber in Germany; 8 the OHIO, Wakayama, and Osaka/Chiba units in Japan; 9–11 the Environmental Exposure Chamber in Canada; 12 allergen Challenge Theatre in Canada; 13 and the Atlanta Allergen Exposure Unit, 14 the…”
Experience with an allergen challenge chamber for clinical trials in allergic rhinitis
Krug, N., Badorrek, P., & Hohlfeld, J. M. (2012) · Clinical & Experimental Allergy Reviews · doi:10.1111/j.1472-9733.2012.01164.x · Cited by 7
Khayath, N., Radu, C. C. P., Choual, I., Jilani, S., Vecellio, L., Domis, N., & Frederic de, B. L. A. Y. (2018) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2018.01.005 · Cited by 6
Update on the use of allergen challenge chambers in immunotherapy: clinical implications.
Zieglmayer, P. U., & Pfaar, O. (2022) · PubMed · doi:10.1097/aci.0000000000000808 · Cited by 5
Sublingual allergen immunotherapy for respiratory allergies: what is new?
Makatsori, M., & Calderón, M. A. (2014) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2014.982536 · Cited by 5
Trial of pranlukast inhibitory effect for cedar exposure using an OHIO chamber
Endo, S., Gotoh, M., Okubo, K., Hashiguchi, K., Suzuki, H., & Masuyama, K. (2012) · Journal of Drug Assessment · doi:10.3109/21556660.2012.703630 · Cited by 4
Self-citationPranlukast hydrate in the treatment of pediatric bronchial asthma
Yoshihara, S. (2013) · Pediatric Health Medicine and Therapeutics · doi:10.2147/phmt.s29461 · Cited by 4
Miki, K. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.164745 · Cited by 3
Zemelka‐Wiącek, M. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237268 · Cited by 5
Effects of induced allergic rhinitis on endogenous epinephrine
Casale, T. B., Ellis, A. K., Camargo, C. A., Spergel, J. M., Bernstein, D. I., Oppenheimer, J. J., Fleischer, D. M., & Tanimoto, S. (2025) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2025.05.008 · Cited by 3
Hashiguchi, K., Okubo, K., Wakabayashi, K., Tanaka, N., Watada, Y., Suematsu, K., & Gotoh, M. (2012) · Journal of Drug Assessment · doi:10.3109/21556660.2012.728547 · Cited by 3
Self-citationHashiguchi, K., Okubo, K., Inoue, Y., Numaguchi, H., Tanaka, K., Oshima, N., Mehta, A., Nishida, C., Saito, I., & Philip, G. (2018) · Allergy & Rhinology · doi:10.1177/2152656718783599 · Cited by 3
“We used an allergen exposure chamber (OHIO Chamber) in this study to allow for exposure to a fixed number of pollen grains in a stable setting, irrespective of variable environmental factors.(11)”
MethodSelf-citationKanzaki, S., Hashiguchi, K., Wakabayashi, K., Suematsu, K., & Okubo, K. (2016) · Journal of Drug Assessment · doi:10.1080/21556660.2016.1237365 · Cited by 2
Self-citationHashiguchi, K., Kanzaki, S., Wakabayashi, K., Tanaka, N., Kawashima, K., Suematsu, K., Tokunaga, S., Ogawa, K., & Okubo, K. (2013) · Journal of Drug Assessment · doi:10.3109/21556660.2013.829070 · Cited by 2
Self-citationHosoya, K., Masuno, S., Hashiguchi, K., & Okubo, K. (2014) · Journal of Drug Assessment · doi:10.3109/21556660.2014.960969
Self-citationHashiguchi, K., Suematsu, K., Masyama, K., Endo, S., Gotoh, M., & Okubo, K. (2010) · Nihon Bika Gakkai Kaishi (Japanese Journal of Rhinology) · doi:10.7248/jjrhi.49.127
Self-citation
Metadata
- Authors
- Hashiguchi, K., Tang, H., Fujita, T., Suematsu, K., Tsubaki, S., Nagakura, H., Kitajima, S., Gotoh, M., & Okubo, K.
- Affiliations
- Kitasato Institute Hospital (JP)
- Shinryo (Japan) (JP)
- Shinryo Corporation (Japan) (JP)
- Chiba Hokusou Hospital (JP)
- Nippon Medical School (JP)
- Venue
- International Archives of Allergy and Immunology
- Publisher
- S. Karger AG
- Published
- 2009
- Volume
- 149
- Issue
- 2
- Pages
- 141-149
- ISSN
- 1018-2438 (ISSN-L)
- 1423-0097
- OpenAlex
- W2146701093
- Cited by
- 31
- References
- 16
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 2 · 2022: 2 · 2021: 1 · 2018: 3 · 2016: 5 · 2014: 5 · 2013: 3 · 2012: 4
- FWCI
- 2.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- International Archives of Allergy and Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Keywords
- Japanese cedar pollinosis, Japanese cedar pollen, pollen concentration, nasal symptoms, ocular symptoms, sneezing, rhinorrhea, seasonal variation
- MeSH terms
- Adult, Allergens, Atmosphere Exposure Chambers, Double-Blind Method, Female, Rhinitis, Allergic, Seasonal, Humans, Male, Middle Aged, Pollen, Reproducibility of Results, Cross-Over Studies, Inhalation Exposure, Cryptomeria
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.